![]() |
市場調查報告書
商品編碼
2041885
雙能量X光吸收(DXA)市場檢測法—按類型、技術、應用、最終用戶和地區分類的全球分析—2034年Dual Energy X-ray Absorptiometry Market Forecasts to 2034 - Global Analysis By Type (Portable and Standalone), By Technology (Advanced Software, Artificial Intelligence (AI) and Other Technologies), Application, End User and By Geography |
||||||
全球雙能量 X光檢測法(DXA) 市場預計到 2026 年將達到 8.246 億美元,並在預測期內以 10% 的複合年成長率成長,到 2034 年達到 17.676 億美元。
雙能量X光檢測法(DEXA)是一種醫學影像技術,用於測量骨骼密度(BMD)和身體組成。它利用兩種不同能量的X光,量化特定身體部位的骨骼、脂肪和瘦組織的含量,從而為骨質疏鬆症診斷、骨折風險評估以及用於醫療和研究的身體組成評估提供高精度、低輻射的評估方法。
根據世界衛生組織統計,非傳染性疾病和慢性病每年導致全球整體約4,100萬人死亡,佔所有死亡人數的74%。國際骨質疏鬆症基金會的一項研究預測,到2020年,亞洲骨質疏鬆症和骨量減少症患者人數將達到2.866億,到2050年將達到5.333億。
骨質疏鬆症和骨骼相關疾病的盛行率增加
骨質疏鬆症和骨骼相關疾病的日益普遍是雙能量X光檢測法(DEXA)市場的主要促進因素。人口老化和久坐的生活方式加劇了骨質疏鬆症的發生率,因此早期診斷和監測至關重要。 DEXA在評估骨骼密度方面的準確性有助於早期發現骨質疏鬆症,從而能夠及時介入以降低骨折風險。此外,人們對骨骼健康管理的日益重視和積極措施也促進了全球對DEXA系統的需求成長,進而推動了市場發展。
DEXA設備和維護高成本
雙能量X光吸收儀(DEXA)設備所需的高額初始投資阻礙了小規模醫療機構和診所採用這項技術。此外,設備維護、校準和軟體更新等持續性成本進一步增加了整體擁有成本,限制了其普及和應用,尤其對於預算有限的醫療機構而言,最終阻礙了市場成長。
人們對骨骼健康和預防措施的認知不斷提高
隨著人們對骨質疏鬆症、骨折及相關骨骼疾病的認知不斷提高,他們開始尋求早期診斷方法。這種意識推動了預防性醫療保健概念的普及,鼓勵定期篩檢和骨骼密度檢測。因此,醫療機構和診斷中心對雙能量X光吸收儀(DEXA)掃描的需求日益成長,隨著越來越多的人重視預防措施和早期檢測以維持最佳骨骼健康,市場也隨之成長。
對輻射暴露和監管限制的擔憂
輻射暴露和監管限制對市場構成重大威脅。雖然雙能量X光吸收法(DEXA)掃描通常劑量較低,但累積輻射暴露問題依然存在,尤其是在頻繁篩檢和孕婦等易感人群中。嚴格的輻射安全法規進一步影響了設備的使用和可用性。遵守嚴格的操作規程、輻射安全措施和訓練要求增加了DEXA部署的複雜性和成本。此外,隨著法規的不斷變化,可能需要持續的技術進步來降低輻射劑量,同時保持診斷的準確性。
新冠疫情導致非緊急醫療程序(包括骨骼密度檢測)延誤,擾亂了市場。診所關閉、病患就診量減少以及醫療資源被轉移至疫情應對,都限制了雙能量X線吸收儀(DEXA)的使用。供應鏈中斷影響了設備的生產和分銷,阻礙了市場成長。此外,患者對前往醫療機構的擔憂以及優先考慮緊急醫療需求而非預防性篩檢的傾向,進一步加劇了疫情期間的市場混亂。
在預測期內,骨折管理板塊預計將成為最大的板塊。
鑑於骨質疏鬆相關骨折病例數量不斷增加,尤其是在老年族群中,預計骨折管理領域將在預測期內推動市場成長。雙能量X光檢測法(DEXA)在評估骨骼健康和骨折風險,以及製定骨折管理策略和治療方案方面發揮著至關重要的作用。隨著人們對預防醫學的日益關注以及對早期發現骨骼相關問題的需求不斷成長,預計骨折管理領域將在市場中顯著成長。
在預測期內,醫院和診所領域預計將呈現最高的複合年成長率。
預計在預測期內,醫院和診所板塊將呈現最高的成長率,這主要得益於骨質疏鬆症和代謝性疾病診斷需求的不斷成長。醫院和診所作為基層醫療中心,能夠方便地為患者提供雙能量X光吸收儀(DEXA)檢測,以評估其骨骼健康狀況。此外,這些機構提供全面的醫療保健服務,並在骨骼密度檢測和身體組成分析方面發揮著至關重要的作用,而這些檢測和分析對於診斷多種疾病至關重要,從而推動了該板塊的成長。
由於亞太地區老年人口不斷成長、醫療基礎設施不斷完善以及骨質疏鬆症及相關疾病的患病率日益上升,該地區有望佔據市場佔有率的領先地位。這些因素正在推動雙能量X光檢測法法(DEXA)系統的需求。此外,中國、印度和日本等國不斷成長的醫療支出、技術的進步以及政府的支持,也鞏固了該地區在DEXA市場的領先地位,並創造了巨大的成長機會。
由於醫療保健支出不斷成長、老年人口不斷增加(老年人患骨質疏鬆症的風險較高)以及對預防醫學日益重視,北美地區預計將迎來顯著成長。此外,醫療保健基礎設施的技術進步和主要市場參與者的存在也促進了該地區的成長潛力。同時,人們對骨骼健康的日益關注以及對早期診斷和治療的高度重視,進一步加速了雙能量X光檢測法法(DEXA)系統在北美普及的應用。
According to Stratistics MRC, the Global Dual Energy X-ray Absorptiometry Market is accounted for $824.6 million in 2026 and is expected to reach $1767.6 million by 2034 growing at a CAGR of 10% during the forecast period. Dual-energy X-ray absorptiometry is a medical imaging technique that measures bone mineral density (BMD) and body composition. Using two X-ray energy levels, it quantifies the amount of bone, fat and lean tissue in specific body regions, aiding in diagnosing osteoporosis, assessing fracture risk, and evaluating body composition for medical or research purposes with high precision and low radiation exposure.
According to WHO, non-communicable diseases and chronic diseases account for around 41 Million deaths globally equivalent to 74%. According to IOF research, the number of individuals in Asia with osteoporosis and osteopenia is anticipated to climb to 286.6 million by 2020 and 533.3 million by 2050.
Increasing prevalence of osteoporosis and bone-related disorders
The increasing prevalence of osteoporosis and bone-related disorders acts as a significant driver in the dual-energy X-ray absorptiometry market. With an aging population and sedentary lifestyles, osteoporosis incidence rises, necessitating early diagnosis and monitoring. DEXA's precision in assessing bone mineral density aids in the early detection of osteoporosis, enabling timely intervention to mitigate fracture risks. Additionally, the expanding awareness and proactive measures to manage bone health contribute to the growing demand for DEXA systems globally, driving market growth.
High cost of DEXA equipment and maintenance
The initial investment for acquiring DEXA machines is substantial, deterring smaller healthcare facilities or clinics from adopting this technology. Additionally, ongoing expenses related to equipment maintenance, calibration and software updates further contribute to the overall cost of ownership, limiting accessibility and adoption, particularly for healthcare institutions with constrained budgets, thereby impeding market growth.
Growing awareness of bone health and preventative measures
Heightened consciousness regarding osteoporosis, fractures and related bone disorders prompts individuals to seek early diagnostic methods. This awareness fosters proactive healthcare approaches, encouraging regular screenings and bone density assessments. Consequently, healthcare providers and diagnostic centers witness heightened demand for DEXA scans, driving market growth as more people prioritize preventive measures and early detection to maintain optimal bone health.
Radiation exposure concerns and regulatory constraints
Radiation exposure concerns and regulatory constraints pose a significant threat to the market. While DEXA scans generally involve low radiation doses, concerns persist regarding cumulative exposure, especially in frequent screenings or for sensitive populations like pregnant women. Stringent regulations on radiation safety further impact device usage and accessibility. Compliance with strict protocols, radiation safety measures, and training requirements adds complexity and cost to DEXA implementation. Moreover, evolving regulations may demand continuous technological advancements to reduce radiation while maintaining diagnostic accuracy.
The COVID-19 pandemic disrupted the market by causing delays in non-essential medical procedures, including bone density scans. Clinic closures, reduced patient visits and diverted healthcare resources toward pandemic response limited DEXA utilization. Supply chain disruptions affected equipment manufacturing and distribution, impacting market growth. Moreover, patient concerns about visiting healthcare facilities and prioritizing essential medical needs over preventive screenings further contributed to the market disruption during the pandemic.
The fracture management segment is expected to be the largest during the forecast period
The fracture management segment is anticipated to lead during the forecast period due to rising cases of osteoporosis-related fractures, especially among aging populations. Dual Energy X-ray Absorptiometry plays a crucial role in assessing bone health and fracture risk and guiding fracture management strategies and treatments. With a growing emphasis on preventive healthcare and the need for early detection of bone-related issues, the fracture management segment is projected to witness substantial growth within the market.
The hospitals & clinics segment is expected to have the highest CAGR during the forecast period
The hospitals and clinics segment is anticipated to exhibit the highest growth rate during the forecast period due to increased diagnostic needs for osteoporosis and metabolic disorders. Hospitals and clinics serve as primary healthcare centers, facilitating patient access to DEXA scans for bone health assessments. Moreover, these facilities offer comprehensive healthcare services, making them pivotal for bone density screenings and body composition analyses, which are essential for various medical conditions, driving the segment's growth.
Asia Pacific is poised to lead in market share due to the region's expanding geriatric population, rising healthcare infrastructure and increasing prevalence of osteoporosis and related conditions, which drive the demand for Dual Energy X-ray Absorptiometry (DEXA) systems. Additionally, growing healthcare expenditure, technological advancements and supportive government initiatives in countries like China, India and Japan contribute to the region's dominance in the DEXA market, fostering substantial growth opportunities.
The North American region is poised for substantial growth owing to increasing healthcare expenditure, a rising geriatric population susceptible to osteoporosis and a growing emphasis on preventive healthcare. Additionally, technological advancements in healthcare infrastructure and the presence of key market players contribute to the region's growth potential. Moreover, heightened awareness about bone health and a strong focus on early diagnosis and treatment further drive the adoption of Dual Energy X-ray Absorptiometry systems in North America.
Key players in the market
Some of the key players in Dual Energy X-Ray Absorptiometry Market include Aurora Spine, BeamMed Ltd., Demetech AB, Diagnostic Medical Systems Group, Echolight S.p.A., Eurotec Medical Systems, Furuno Electric Co., Ltd., GE Healthcare, Hologic, Inc., Lone Oak Medical Technologies LLC, Medilink International, Medimaps Group, Osteometer Meditech Inc., OsteoSys Co., Ltd., SCANCO Medical AG, Shenzhen X-ray Equipment Co., Ltd. and Swissray Global Healthcare Holding Ltd.
In September 2023, Medimaps Group, a Swiss/Global med-tech company specializing in image-processing software with AI capabilities for assessing bone health, announced today it received the Medical Device Regulation (MDR) certification from its notified body BSI (CE 2797) for its management system and product portfolio.
In February 2022, Aurora Spine partnered with Echolight Medical, the manufacturer of the radiation-free EchoS portable densitometer utilized to assess the quality of the software platform and the bone mineral density (BMD) in the patients affected. The two companies decided to advertise one other's products to their respective clients and prospects as part of the Aurora DEXA Platform.